The functions of neurotrophins in relation to axon growth and branching during development of the nervous system are unknown.
In order to address this question, we have investigated the influences of systemically administered mouse nerve growth factor (mNGF) and human recombinant neurotrophin3 (hrNT-3) on dorsal root axon growth in the spinal cord of embryonic rats. As anticipated, mNGF has a marked influence on growth of dorsal root axons. In mNGFtreated animals, dorsal root axons in the developing dorsal funiculi and axon collaterals in developing gray matter are substantially longer than those of age-matched controls. Furthermore, growth cones of some dorsal root axons have more than twice the surface area of controls. These effects of NGF are highly selective.
Dorsal root axons that occupy a lateral position in white matter and that normally give off collaterals to superficial dorsal horn are prominently affected. Axons that run medially in dorsal columns and that give off collaterals to laminae Ill and IV and the ventral horn are not demonstrably influenced by treatment with exogenous mNGF.
In contrast to the striking effects of mNGF on dorsal root axon growth, the influences of hrNT3 were considerably more complex. Administration of hrNT3 increased the mean soma area of DRG neurons, particularly those at the larger end of the size spectrum, consistent with its hypothesized role as a growth factor for proprioceptive sensory neurons. However, in striking contrast to the actions of mNGF, hrNT-3 consistently inhibited axon collateral growth in gray matter at early developmental stages. At later stages, we could not discern a clear-cut influence of hrNT3 on dorsal root axon growth and branching.
We conclude that the ability of mNGF to stimulate axon growth in both white and gray matter is consistent with the idea that mNGF regulates the developing axonal projections of DRG neurons in viva. In contrast, systemically administered hrNT3 inhibits the axon collateralizations of DRG neurons in gray matter at early developmental stages. We hy-
The remarkable ability of NGF to promote neurite outgrowth from sensitive neuronal populations was the key activity that led to its purification (see Levi-Montalcini and Angeletti, 1968 , for a review). Neurite outgrowth remains in common use as a bioassay for NGF, and more recently described members of the neurotrophin family share this activity. Neurite outgrowth induced by NGF is equally impressive in vivo and has been documented in both the PNS and CNS (Levi-Montalcini and Hamburger, 195 1; Olson et al., 1967; Menesini-Chen et al., 1978; Hagg et al., 1992; Kawaja et al., 1992) . Surprisingly, the precise functions subserved by this neurite outgrowth-promoting activity during development are unknown. Three functions have been proposed: (1) growth factors regulate neural differentiation and axon growth is a concomitant of the differentiation program (see Snider and Johnson, 1989 , for a review); (2) growth factors attract growing axons into target fields (chemotropism) (Menesini-Chen et al., 1978; Tessier-Lavigne et al., 1988; Bolz et al., 1990; Heffner et al., 1990; Tessier-Lavigne and Placzek, 1991 ; see also Gunderson and Barrett, 1979, 1980) ; and (3) growth factors regulate the density of axon branching and synaptic rearrangement in target fields during development (Olson et al., 1967; Korsching and Thoenen, 1983; Shelton and Reichard& 1984; Maffei et al., 1992) . There is currently insufficient experimental evidence to conclude whether any or all of these theories may be correct. Investigations on whether growth factors regulate the growth of axons have lagged behind studies on other aspects of growth factor function, primarily because such effects are more difficult to visualize and quantitate . A further difficulty in the case of axon growth is that it is desirable to assess effects in embryonic life when axons are growing toward their targets, a fact that complicates the delivery of growth factors and their antibodies.
In the present study we have characterized the influence of three neurotrophins on axon growth in the embryonic rat spinal cord in vivo. We have chosen the DRG system because all known neurotrophins promote survival and neurite outgrowth of DRG neurons in vitro (Davies et al., 1986; Leibrock et al., 1989; Hohn et al., 1990; Maisonpierre et al., 1990; Berkemeier et al., 199 1) . Furthermore, human recombinant BDNF and NT-3 have recently become available in quantities adequate for in vivo ex-periments. In order to assess the effects of neurotrophins, we have stained the DRG projection with the intensely fluorescent, lipid-soluble tracer DiI, which fully stains axons and their branches in fixed tissue (Honig and Hume, 1986; Godement et al., 1987) . We have delivered neurotrophins at an early stage prior to the arrival of DRG axons in their target fields using a well-established protocol of direct injections in utero (Kessler and Black, 1980; Goedert et al., 1984; Johnson et al., 1989; Ruit et al., 1992) .
We show here that mNGF strikingly enhances dorsal root axon growth in both white and gray matter of the developing rat spinal cord. Furthermore, growth cones of particular populations of dorsal root axons have more than twice the surface area of controls. Finally, the effects of mNGF are selective for axons that run laterally in dorsal white matter and normally terminate in the superficial dorsal horn. In contrast, effects of hrBDNF and hrNT-3 on axon growth were considerably more complex, and hrNT-3 consistently inhibited axon collateral branching in spinal gray matter at early developmental stages. We hypothesize that these inhibitory effects of hrNT-3 may be related to the widespread expression of a truncated form of the NT-3 receptor t&C TK-by non-neuronal cells or to disruption of a chemotropic gradient involving NT-3.
Materials and Methods
Neurotrophins. Mouse NGF, purified according to a standard protocol (Bocchini and Angeletti, 1969) was generously provided by E. M. Johnson, Jr. and P. Osborne. Recombinant human BDNF and NT-3 were produced in Escherichia coli and transfected with BDNF or NT-3 expression vectors. BDNF and NT-3 were purified to homogeneity by the protein chemistry group at Amgen as previously described (Spina et al., 1992) . The bioloaical activities of BDNF and NT-3 were routinely assessed using a chicken DRG explant assay (Lindsay et al., 1985) . -In utero injections. Pregnant Sprague-Dawley rats (Sasco, Omaha, NE and Harlan, Indianapolis, IN) at 14 or 15 d gestation were anesthetized with a cocktail of ketamine HCI (Vetalar; 100 mg/ml), xylazine (Rompun; 20 mg/ml), and acepromazine maleate (PromAce; 10 mg/ ml) in a 3:3: 1 mixture by volume. A 0.7 ml/kg dose of the cocktail was administered intramuscularly, resulting in a deep anesthesia. Individual embryos were injected in utero using methods previously outlined in detail . Growth factors and control solutions were drawn up in a 50 ~1 Hamilton syringe with an attached 30 gauge needle. mNGF was dissolved with L 15 (Sigma), and hrNT-3 and hrBDNF were dissolved with sterile 0.85% saline. Age-matched embryos used as controls in senarate litters received iniections of L15 (for mNGF) or 0.85% saline (for hrNT-3 and hrBDNF):
Neurotrophins were administered by two separate injections, on El4 and E15, El5 and E16, or El5 and E17. Embryos were then taken individually by cesarean section at E 16, E 17, or E 19, respectively. For mNGF, 10 ~1 of a 1 mg/ml solution was injected into each embryo. For hrNT-3 and hrBDNF, 10 ~1 of either a 0.25 mg/ml or a 0.5 mg/ml solution was injected. In our hands, embryos did not survive treatment with higher dosages of hrNT-3. It also should be noted that injections on El4 were associated with a high rate of fetal wastage (-75%).
DiI labeling. The embryos were anesthetized by hypothermia and perfused through the left ventricle with 4% parafonnaldehyde in 0.1 M phosphate buffer (pH 7.4). After the embryos had been postfixed for 24 hr, the spinal cords and DRGs were removed and small crystals of the intensely fluorescent, lipid-soluble tracer DiI (1. I'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; Molecular Probes) were placed in DRGs according to methods outlined in detail previously Snider et al., 1992) . In order to eliminate the intersegmental variability in the dorsal root projection, only the C5 (for transverse sections) or T6 (for parasagittal sections) DRGs were labeled. In some cases, in order to label the cutaneous dorsal root afferent projections selectively, large crystals of DiI were placed in the skin on the dorsum of the embryo. When the crystals were placed directly in the DRGs, specimens were kept in 10% formalin at 37°C from 5 d (El6 and El 7) to 7 d (E19). For the skin preparations, incubation times ranged from IOdto 14d.
The extent of DiI labeling of axons can be influenced by a variety of parameters including the size of the DiI crystal, composition of fixative, length of time in fixative prior to labeling, and temperature and length of time at which specimens are maintained (Godement et al., 1987; Snider and Palavali, 1990) . It is important to note that all El 6 specimens were maintained in 10% formalin at 37" for 5 d for both control and neurotrophin-treated groups. E 19 specimens were maintained for 7 d. A technical issue that could have affected our results is the potential for DiI to spread in the dorsal columns and funiculi to label axons that did not originate in the labeled DRG. In experiments where this issue has been explicitly addressed, the evidence suggests that DiI does not spread to label adjacent unlabeled axons (Simon and O'Leary, 1992) . Although we cannot exclude the possibility of spread to unintended axons, if such spread indeed occurred, there is no reason to suspect that it systematically occurred more or less often in neurotrophin-treated animals as compared to controls.
After the appropriate time interval, spinal cords were embedded in agar and sectioned on a vibratome in the transverse or parasagittal planes at 75 wrn thickness. Sections were photographed and suitable sections were selected for tracing by camera lucida. In many sections, photoconversion was carried out by utilizing 3,3'-diaminobenzidine tetrahydrochloride (DAB) according to a previously published protocol (Sandell and Masland, 1988; Snider et al., 1992) .
In some preparations, axons in the dorsal and dorsolateral funiculi were visualized in an effort to quantitate the rate of axon growth in white matter. For these preparations, the spinal cord was first sectioned in the parasagittal orientation and the hemicord with the DiI-labeled C5 dorsal root and DRG attached was saved for visualization of DiIstained axons. Using iridectomy scissors, the dorsal and lateral funiculi were peeled away from the underlying gray matter, and flattened on a slide under a coverslip with the lateral surface up. This procedure allowed us to view all dorsal and dorsolateral funicular axons from the C5 DRG in a single section.
Quantitative analysis. Several aspects of neurotrophin actions on DRG neurons were quantitated. First, we assessed the influence of neurotrophins on DRG neuron soma cross-sectional area. For these studies, C5 DRGs were embedded in Araldite (Sigma, St. Louis, MO) as described previously . Semithin (1 pm) sections were cut in transverse orientation from each DRG and stained with toluidine blue. One section was selected from the central portion of each C5 DRG for tracing under camera lucida at 625 x . Even at this early age neurons were readily distinguishable from glia on morphological grounds. In order to lessen the possibility that profiles of larger cells were oversampled, only neurons with a nucleolus visible in the section were analyzed. DRG neuron somata profiles were then traced on a digitizing tablet interfaced with computer software designed to calculate areas (BIOQUANT, R&M Biomedics) and size-frequency histograms were generated. Because of the large number of experiments required to obtain numbers of cells needed for clear-cut conclusions about neuron size, we concentrated on the effects of mNGF and hrNT-3. For animals treated with hrNT-3, 1205 DRG neurons from 10 embryos from four separate litters were studied. For age-matched controls, 1318 DRG neurons from 12 embryos from five separate litters were analyzed. Three animals were treated with mNGF, and 431 DRG neurons from these animals were analyzed.
In order to determine the effects of mNGF on axon growth in dorsal funiculi, we analyzed projected 35 mm photomicrograph negatives of whole-mount DiI-stained preparations taken at 10 x Medial and lateral parts ofdorsal funiculi were analyzed separately because different classes of axons enter the cord in different mediolateral locations. The rostra1 extension was divided into three parts yielding a total of six squares with dimensions 1.2 x 1.2 mm each. The number of axons in each square was counted and scored as follows: 4, axon number > 100; 3, axon number between 50 and 100; 2, axon number between 25 and 50; 1, axon number between 5 and 25; 0, axon number < 5.
Effects of mNGF on particular classes of dorsal root afferents were examined by measuring growth cone areas of dorsal root axons in preparation where axons could be traced from their entry zone in gray matter to their growth cones. Many of the best preparations were from skinlabeled material because fewer axons were labeled than in the preparations where DiI was placed in the DRG. Axons were placed into three rough categories: (1) axons projecting to the ventral horn (Ia afferents)-the term "Ia" is used throughout to refer to the central axons of DRG neurons that innervate the primary endings of muscle spindles in the periphery and have monosynaptic contact on motor neurons (see Snider In contrast, hrNT-3 (E, P') increased the size of larger neurons and thus accentuated cell size differences within the ganglion. Scale bars, 20 pm. et al., 1992); (2) axons entering medially, projecting ventrally to laminae IV and V, and turning upward to terminate in lamina III-many of these have the characteristic morphology of hair follicle afferents (see Snider et al., 1992 , for a discussion); (3) fibers entering laterally and projecting ventrally or circumferentially-these latter fibers were confined to laminae 1 and II in control animals, although they projected somewhat more ventrally in mNGF-treated animals. Growth cones were traced and analyzed quantitatively in 17 photoconverted sections of C5 DRGs from four control animals and 16 sections of C5 DRGs from six mNGF-treated animals. At least 100 growth cones in each group were traced under camera lucida in control and mNGF-treated animals at 1250 x . Growth cone areas were determined by a computerassisted method using software for neuronal morphometry (BIOQUANT) . Areas of growth cones in all of those groups were compared with agematched controls using one-way ANOVA (see Table 2 ). In a few experiments, surface areas of growth cones from animals treated with hrNT-3 were also comnuted.
Finally, we quantitaied the length of fascicles of dorsal root axon Figure 2 . Histograms of DRG neuron soma areas at E 16 in control and neurotrophin-treated animals generated using pooled data from neurons in all experiments. As expected, mNGF (hatched bars) had striking effects on DRG neuron size. The primary effects of mNGF treatment were to decrease the percentages of neurons in the 50 pm2 and 100 pm2 bins and to increase the percentage of neurons in the 150 pm2 bin. Treatment with hrNt-3 (white bars) produced very different results. Neurons with areas between 50 and 150 pm2 were slightly reduced in frequency compared to controls, whereas neurons between 150 and 200 pm* almost doubled in frequency. Note that less than 2% of DRG neurons in control animals have soma areas of >200 pm' at E16. In contrast, almost 16% of DRG neurons in hrNT-3-treated animals were this large.
collaterals branching into gray matter at E16. The length of fascicles measured from dorsal funiculi to their maximum ventral extent was determined from photomicrographs of parasagittal sections of thoracic spinal cord after labeling the T8 DRG. As the dorsoventral extent of the Ia projection will depend on the mediolateral position ofthe section, for each animal the section showing the maximum ventral extent of axons was chosen for analysis. Sections from eight animals treated with hrNT-3 and five animals treated with hrBDNF were compared with sections from six age-matched controls. The different groups were compared using one-way ANOVA.
Results

NGF and NT-3 affect DRG neurons of deferent sizes
We first sought to verify that our in utero injections of neurotrophins would have demonstrable effects on DRG cells. We therefore assessed the sizes of dorsal root ganglia and of individual DRG neurons in embryos treated with mNGF and hrNT-3 and in controls treated with saline. The ganglia of mNGF-treated animals were markedly larger than controls, whereas treatment with hrNT-3 only slightly increased the overall size of the ganglia. High-power photomicrographs from semithin sections revealed that both mNGF and hrNT-3 increased soma crosssectional areas of DRG neurons, but that the two neurotrophins appeared to affect different populations of DRG neurons ( In order to quantitate the effects of neurotrophins on individual DRG neurons, we examined DRG cells under high power in semithin plastic sections and traced cell soma profiles for size-frequency histograms. Histograms generated from pooled data from all experiments are shown in Figure 2 . Histograms from control animals (black bars) at this age showed a range of sizes with the greatest percentage of DRG neurons falling in the 100 pm* bin (50-100 pm* size range). As expected, the sizefrequency histogram was shifted to the right toward larger soma areas in mNGF-treated animals (hatched bars). In particular, the smallest class of neurons, less than 50 wrn*, was almost Fi.qure 3. C5 dorsal root axons in developing funiculi in control and mNGF-treated animals at El 6. The D&stained dorsal root axons are viewed from the dorsal surface of the spinal cord in whole-mount preparations. A-D are photomicrographs; E-H are camera lucida tracings. Open arrows in A and B denote DRGs. M, medial; L, lateral. A, Low-power view of the C5 projection in the dorsal funiculi from a control embryo. Note a medial band of axons (thick arrows) presumably from proprioceptive and mechanoreceptive DRG neurons that project to the dorsal column nuclei. Asterisk denotes axons occupying more lateral regions that presumably are from other classes of DRG neurons. B, In mNGF-treated animals there is a marked increase in the number and length of dorsal root axons that is particularly prominent in the lateral region (asterisk). C, Higher-power view of dorsal root axons from an El 6 control embryo. Vertical arrows denote the lateral fibers. D, The dramatic effects of mNGF on lateral axons (vertical arrows) are obvious. E and F, Camera lucida tracings of DiI-labeled dorsal root axons at E16. The prominent effects of NGF on lateral axons are again apparent. G and H, Higher-power camera lucida tracings of E and Fin the regions of the asterisks. The presence of growth cones in G and H demonstrates that many of these lateral axons were labeled all the way to their distal tips. The enlarged growth cones in the mNGFtreated animals (arrows) are apparent even at this magnification. Scale bars, 100 pm. Axon density was scored on a O-4 scale (4, axon number > 100; 3, axon number = M-100; 2, axon number = 25-50; I, axon number = 5-25; 0, axon number < 5). M and L are medial and lateral dorsal funiculi, respectively; l-3 denote increasing distance from the C5 root entry zone.
completely eliminated by mNGF treatment. Also after mNGF treatment, the majority of DRG neurons were in the 150 pm2 bin (size range 100-150 pm). Interestingly, however, neurons larger than 150 pm2 were not increased in frequency in these mNGF-treated animals.
Treatment with hrNT-3 (white bars) resulted in a completely different pattern. There was little change in the frequency of neurons with soma areas less than 50 prn2. However, neurons with areas between 50 and 150 pm* were slightly reduced in frequency compared to controls, whereas neurons between 150 and 200 pm* almost doubled in frequency. In addition, more than 16% of DRG neurons in hrNT-3-treated embryos had soma areas larger than 200 prn2, as compared to 2% in controls. In hrNT-3-treated animals, 6% of DRG neurons had soma areas of greater than 250 prnz, whereas no DRG neuron in a control population of 13 18 DRG neurons was this large at E 16. mNGF stimulates growth of dorsal root axons in developing dorsal funiculi We next determined whether mNGF could stimulate growth of dorsal root axons in the dorsomedial and dorsolateral funiculi. For these experiments, mNGF was administered by in utero injection on El4 and El 5 and dorsal root axons growing in the funiculi were stained with DiI at El 6. E14, which is 48 hr after rat dorsal root axons first enter the spinal cord and bifurcate into rostrocaudally directed branches (I. Silos-Santiago and W. D. Snider, unpublished observations), is probably the first day at which these in utero injections are feasible (L. Zhang, unpublished observations). The normal appearance of the dorsal root projection in the C5 cervical region at E 16 is shown at low power in Figure 3A and at higher power in Figure 3C . The spinal cords in these animals were sectioned approximately along the midline and mounted on a slide with the dorsolateral surface up in order to view the growing axons. The photomicrographs show the C5 dorsal root ganglion (open arrow) together with dorsal root axons projecting rostrally and caudally in the spinal cord. In control animals (Fig. 3A,C) , a large band of fibers near the midline of the spinal cord (large solid arrows) extends rostrally toward the dorsal column nuclei in the medulla and caudally at least several segments away from the DiI-labeled DRG. These axons are presumably from proprioceptive and mechanoreceptive DRG neurons. The growth cones of the medial axons could not be observed, suggesting that they were not labeled to their farthest rostra1 extent. Axons occupying more lateral aspects of the dorsal funiculi ( Fig. 3A, asterisk ; C, vertical arrows) extended for much shorter distances at this age. Camera lucida tracings of labeled axons from these whole-mount preparations are shown in Figure 3 , E and G. Frequently, growth cones of the most lateral axons (Fig. 3G, arrows) could be observed demonstrating that many of these axons are fully labeled at E16.
The appearance of the C5 dorsal root projection in the mNGFtreated animals is completely different. There was a dramatic increase in the number and length of axons, particularly in the lateral regions (Fig. 3B,D) . Furthermore, it was obvious that growth cones of axons in the lateral region were larger in mNGFtreated animals than in controls (compare Fig. 3, G and H) . Growth cones of lateral fibers in mNGF-treated animals were found to be roughly twice as large as growth cones in control animals (see below). From the anatomical material, it appeared that the effect of NGF was restricted to axons that normally course in the lateral aspect of the dorsal funiculus. However, we cannot exclude the possibility that some medial fibers were also stimulated and crossed over into the lateral region.
In order to quantitate the effects of mNGF injections on neurite outgrowth of dorsal funiculi, 35 mm negatives of photomicrographs from five control and five NGF experiments were divided into six regions (for details, see Materials and Methods). Axon outgrowth in dorsal funiculi was scored according to conventional methodology in each of three medial and three lateral areas. The results are shown in Table 1 . In mNGF-treated animals, there was a marked increase in neurite score in the lateral regions and regions farthest away from the dorsal root entry zone. Such increases in neurite score could be due to increases in the length ofaxons, increases in the numbers ofDRG neurons, branching of individual axons, or some combination of all of these. Distinguishing among these possibilities will require staining the axons of individual dorsal root ganglion cells after NGF treatment. mNGF enhances growth of dorsal root axon collaterals in gray matter In order to address the question of whether mNGF may influence growth of axon collaterals in spinal gray matter, we studied the dorsal root afferent projection in transverse sections of C5 cervical spinal cord. Three time points (E16, El 7, and El 9) were examined after double injections of NGF (see Materials and Methods). These time points were chosen because the first collaterals enter gray matter between E 14 and E 15 in the cervical region . The results of all three paradigms show that NGF strikingly promoted the growth of collaterals of certain classes of dorsal root axons. Examples of our results at E 17 and E I9 are shown in Figure 4 . In NGF-treated animals, axons normally projecting to the superficial dorsal horn were longer and appeared to be more numerous than in controls (compare Fig. 4, A and B, asterisks) . In addition, aberrant bundles of axons projecting toward and frequently crossing the midline could be observed (Fig. 4B, large arrows) . Although a few axons cross the midline in control animals (Fig. 4A, large arrow) in the C5 region, this projection was sparse in every control animal examined (see below). Furthermore, in mNGF-treated animals, multiple crossing bundles were frequently observed, which was never the case in controls. Similar phenomena were observed in El 9 animals after injections of mNGF at El 5 and El 7 (Fig. 4C,D) . There were no obvious effects on the numbers, Figure 4 . The C5 dorsal root afferent projection in spinal gray matter in control and mNGF-treated animals. A and C are photomicrographs of photoconverted sections from controls at El7 (bright-field) and El9 (dark-field). B and D are from NGF-treated animals. A, By El 7 the major classes of dorsal root afferents have entered the gray matter of the spinal cord in the C5 region. Ia afferents to the motor pool are depicted by arrowheads. Small-diameter cutaneous afferents entering laterally and projecting to superficial dorsal horn are denoted by asterisk. Axons entering medially and projecting to laminae III and IV (presumably low-threshold mechanoreceptors) are indicated by thin arrow. Only a few axons cross the midline in the C5 region (thick arrow). B, In animals treated with mNGF on El5 and E16, axons entering laterally are markedly stimulated and are longer and more numerous than in controls (asterisk). Many of these axons project toward the midline in thick bundles (arrows) . In contrast, Ia afferents are not demonstrably affected (arrowheads). C, Dorsal root axons labeled in the CS segment by placement of DiI crystals in skin at E 19. Axons entering laterally and terminating in superficial dorsal horn are denoted by asterisks. Axons entering medially and terminating in laminae III and IV are indicated by the thin arrow. Only the most lateral region of dorsal horn is labeled because crystals were placed on skin along the dorsum of the animal. Again, only a few axons project toward the midline (thick arrows) in this section from a control embryo. D, mNGF treatment at E 15 and E 17 results in marked stimulation of the superficial axons (asterisks) and the formation of axon bundles projecting toward and crossing the midline (thick arrows). A few axons from the crossing bundles grew downward along the midline, a phenomenon never observed in control animals. dh, dorsal horn. Scale bars, 100 hrn.
length, or branching of dorsal root axons projecting to the ven-
The influence of mNGF on dorsal root axon collateralization tral horn (compare Fig. 4, A and B, arrowheads) . However, it at different ages is shown in more detail in the camera lucida should be noted that in DiI-stained material it would be difficult tracings of the C5 dorsal root projection in Figure 5 . In these to exclude an effect of NGF on the numbers of Ia axons, and drawings, small-caliber axons entering laterally and normally this issue will require further study.
terminating in the superficial dorsal horn are rendered in red.
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Pi~urc~ 5. Camera lucida tracings of the C5 dorsal root afferent projection at different ages in control and mNGF-treated animals. Left, E16; middle, E 17; and right, E 19. Top. controls; hottorn, animals injected with mNGF according to Materials and Methods. Different classes of afferents are rendered in different colors. la afferents and afferents entering medially and turning upward (probably hair follicle and other low-threshold mcchanoreceptors) are rendered in hluck. Afferents entering more laterally and occupying the superficial dorsal horn in control animals are rendered in red. Lqfi, Effects of mNGF injections on lateral fibers are readily apparent even at El6 (D). Note that lateral fibers (red) are more numerous and longer, but that there is no effect on medial fibers (black). Middle, In comparing B (control) and E (NGF) at E 17, it is apparent that the fibers rendered in red are longer than in control animals. Fascicles of such fibers frequently project to the midline and cross to the opposite side of the spinal cord. No effects on las or hair follicle afferents (black) were apparent. Right, At El9 the pattern is similar. Axons entering laterally (red) are markedly stimulated by mNGF (F), whereas other classes (black) are not obviously affected. Although a few crossing fibers are present in some segments of C5 in control animals (C), these are much less numerous than animals treated with mNGF (F). Scale bar, 100 rm.
Larger-caliber axons entering medially and terminating in ventral laminae of the dorsal horn and ventral horn are rendered tn black. Striking effects of NGF on lateral fibers are apparent even at E 16, the first day superficial fibers enter the gray matter tn controls (compare Fig. 5, il and D) . A marked increase in numbers of axons entering laterally was observed. Most of these projected toward the midline. In contrast, no effects on fibers entering medially were seen. Effects on these medial axons would have been particularly easy to demonstrate if present because the axons projecting to the ventral horn are short and unbranched at this age.
At El 7, the projections of all classes of dorsal root axons are more developed in control animals (Fig. 5B) . Ia axons have reached the ventral horn and begun to arborize in motor pools. Hair follicle afferents and other low-threshold mechanoreceptors have reached laminae III and IV of the dorsal horn and have turned upward in their characteristic "flame-shaped" appearance. Finally, axons have entered the superficial part of the dorsal horn to terminate laminae I and II. In animals treated with NGF at El 5 and E16, growth of superficial axons was greatly stimulated (Fig. 5E ). Such axons were longer and appeared to be more numerous, and there were aberrant bundles projecting toward and crossing the midline. Again, no effects on afferents terminating in the deeper laminae of the dorsal horn or the ventral horn were obvious. Although we cannot exclude an effect on the number of such axons (it is very difficult to quantitate axon number in these bulk-labeled preparations), it was not apparent that these fibers were any longer in mNGFtreated than in control animals, or that they projected to aberrant locations. At E 19, in control animals, dorsal root axons were longer and terminal arbors are more complex (Fig. 5C ).
The effects of treatment with NGF ( Fig. 5F ) are similar to those observed at younger ages.
It is important to emphasize that the situation with regard to fascicles that cross the midline is complex because in axial (e.g., thoracic) regions of spinal cord there is a substantial projection of crossing axons in normal animals. The increase in numbers of fascicles crossing the midline in mNGF-treated animals was particularly apparent in parasagittal sections that included multiple spinal cord segments. Such sections clearly revealed the massive increase in the number of crossing axons in the NGFtreated animals even in thoracic spinal cord (data not shown).
A final observation of interest is that, to some extent, normal spatial cues that constrain the dorsal root projection were maintained in mNGF-treated animals. The exuberant projections grew toward and frequently crossed the midline to project to the contralateral dorsal horn. As was the case in control animals, virtually no axons that entered the gray matter laterally extended ventrally to reach the ventral horn. Thus, administration of mNGF did not completely override the normal spatial cues that restrict different populations of afferent axons to different regions of the spinal gray matter. Selective influences of NGF on different classes of dorsal root qferents It was apparent in all of these preparations that NGF had marked influences on growth cones of certain classes of axons in spinal gray matter. In order to quantitate this effect, we traced the growth cones of axons that could be assigned to a specific class by the position of entry into the spinal gray matter and the location of the terminal field. For example, growth cones of Ia afferents could be confidently identified because of their location in the ventral horn. Growth cones of other axons could be tentatively identified as hair follicle afferents because the axons entered the spinal gray medially, projected ventrally to laminae IV and V, and then turned upward to terminate in lamina III. Finally, axons that entered the gray matter in the lateral region of the dorsal horn had either a straight or circumferential trajectory and possessed growth cones that were found in laminae I and II in control animals. Growth cones were studied in E 17 animals that had been treated with NGF twice on El 5 and El 6.
It is apparent that NGF had striking effects on growth cones of some classes of afferents, but not on others. Growth cones of lateral fibers were markedly stimulated by NGF (Fig. 3H) . Growth cones of these axons exhibited twice the surface area in mNGF-treated animals as in controls (compare Fig. 3G ,H, and Table 2 ). In contrast, there were no demonstrable effects of NGF on other classes of axons. For example, there were no effects of NGF on the growth cones of Ia afferents or the growth cones of hair follicle afferents.
hrNT-3 inhibits growth of dorsal root axons in gray matter at early developmental stages In order to determine whether these effects of NGF on axon growth and branching generalized to other neurotrophins, influences of BDNF and NT-3 were examined in these same paradigms. It has been hypothesized that NT-3 is a growth factor for proprioceptive DRG neurons, including the Ia muscle afferents that project to the ventral horn (see below). In order to assess the effects of neurotrophins on Ia afferent axons, we studied all fascicles of axons projecting toward the ventral horn in parasagittal sections of spinal cord after labeling the T8 DRG. Preparations were examined at E 16 because it is straightforward to determine the maximum ventral extent of dorsal root axon growth at this early stage. Neurotrophins were administered at El4 and El 5. It is important to note that at E14, Ia axons have not yet penetrated spinal gray matter . Figure  6 shows midthoracic spinal cords from these preparations at 4 x (left panels) and 10 x (right panels) magnifications. The ventral edge of the cord is denoted by dashed lines in the left panels. Arrows on the right denote the maximum ventral extent of fascicles of Ia axons. In control animals at El6 (Fig. 6A,B ; Table 3 ), Ia axons have projected more than halfway to the motor pools in the ventral region. In animals treated with hrBDNF at El4 and El 5 (Fig. 6C,D ; Table 3) , we see neither an increase nor a decrease compared to controls in the ventral extent of this projection.
Treatment with hrNT-3 (Fig. 6E,F) produced very clear-cut and surprising results. In each of seven animals examined in three separate litters, treatment with hrNT-3 resulted in inhibition of axon growth in gray matter. Thus, Ia axons projecting to ventral horn had grown only 25% of the way along the dorsoventral axis by E 16 in hrNT-3-treated animals. The magnitude of this effect was quantitated and the results of all experiments are shown in Table 3 . Observations in the transverse plane from the lumbar region ofthe spinal cord at El 6 confirmed this inhibitory effect (Fig. 7A,B) . It is important to emphasize that this inhibitory effect on axon growth in gray matter is not inconsistent with the fact that hrNT-3 may influence DRG neuron survival or increase cell size (Hory-Lee et al., 1993; see above) . No judgement could be made about the numbers of fascicles or individual axons that could have been increased in animals treated with neurotrophins, but could not be measured accurately with these methods. Figure 6 . Influences of neurotrophins on dorsal root axon growth in gray matter at early developmental stages. Panels show low-power (left) and higher-power (right) photomicrographs of parasagittal sections of midthoracic spinal cord at El6 in control and neurotrophin-treated embryos. Animals were treated on E 14 and El 5. A and B, Control. C and D, hrBDNF treated. E and F, hrNT-3 treated. In all preparations the left T8 DRG was labeled with DiI. Dorsal root axon collaterals project toward, but have not reached, the ventral horn at this age. The ventral edge of the spinal cord is denoted by dashed lines in the left panels. In the right panels, arrows denote the maximum ventral extension of dorsal root axon collaterals. In comparison with control (A. B) and hrBDNF-treated animals (C, D), axon growth in gray matter was clearly inhibited in animals treated with hrNT-3 (E, F). Scale bars, 100 pm.
The effects of hrBDNF and hrNTA3 were also examined in shown). In a few preparations we determined the area of growth older animals. Embryos were treated at E 15 and El 7 and excones of Ia axons in NT-3-treated animals. Ia axons from NTamined at El 9. It is important to stress that minor differences in the dorsal ferences in the dorsal root projection between control (C) and root projections between control and neurotrophin-treated anhrNT-3-treated animals (0) are apparent. In particular, in hrNTimals could have been missed. For example, if hrNT-3 influ-3-treated animals (C), Ia axons were not longer, did not project ences survival of some DRG neurons, one may expect to see into inappropriate regions, and did not appear to be excessively increased numbers of Ia axons. There was no accurate way to branched. Results for hrBDNF treatment were similar (data not quantitate the number of fascicles or number of axons per fas- cicle in this material. Furthermore, effects on subtle parameters such as terminal branching would not have been demonstrated using these techniques. Interestingly, inhibitory effects of hrNT-3 were no longer apparent in these older animals. However, these animals were given their first treatment at E 15, a stage at which Ia axons have already penetrated the gray matter of the spinal cord. In order to pursue this issue further, in four animals, treatment was begun at E14. Even in these animals, some Ia axons were visualized in the ventral horn by E17, suggesting that inhibitory effects do not result in permanent changes in organization of the dorsal root projection (data not shown).
Discussion
NGF regulates rate of axon growth An essential finding of this study is that exogenous mNGF enhances dorsal root axon growth in spinal axon tracts and gray matter in viva. Thus, at early stages, some classes of dorsal root axons extend roughly twice as far in white matter as controls. Growth of dorsal root axon collaterals in gray matter is also enhanced. The fact that axons have extended farther over a given time period suggests that NGF regulates the rate of axon growth in the spinal cord. It is also probable that NGF influences the number of dorsal root axons in the funiculi via effects on DRG neuron survival and axon branching (see Erzurumlu et al., 1992; Li et al., 1993) . We could not be confident about effects on axon number using the bulk-labeling methods employed in this study.
The increase in rate of axon growth observed here obviously parallels the well-established effects of NGF on neurite outgrowth from DRG explants in vitro. Indeed, the scoring system we employed to quantitate axon growth was derived from similar systems used in vitro that score neurite outgrowth as a bioassay for NGF. NGF-induced axon growth in vitro is associated with upregulation of mRNA for microtubule associated proteins (MAPS), as well as phosphorylation of MAPS, effects that are thought to increase tubulin polymerization (Drubin et al., 1985 (Drubin et al., , 1988 Aletta et al., 1989) . Although no evidence as yet speaks to the role of MAPS or other cytoskeletal elements in regulating growth factor actions on axon elongation during development in vivo, it will be straightforward to address this issue using standard techniques to quantitate gene expression in NGF-treated embryos.
What are the functions of this regulation of rate ofaxon growth by NGF in vivo? An important implication of this finding is that growth factors are part of complex regulatory mechanisms that cause or allow axons to arrive in target fields at appropriate times in relation to the onset of synaptogenesis. Obviously, the timing of axon branching into target fields must be coordinated with the synthesis of synapse-specific molecules by postsynaptic cells. Arrival of axons too early or too late in the target field may disrupt normal connectivity (Goodman and Shatz, 1993) . Interestingly, for DRG neurons, this regulation of rate of axon growth in spinal cord is probably in response to peripheral target-derived NGF. Thus, some DRG neurons express NGF receptors and presumably have access to peripheral sources of NGF by El 3, which is well before they branch into gray matter of the spinal cord (for data on NGF mRNA synthesis in developing mouse, see Davies et al., 1987; Schecterson and Bothwell, 1992 ; see also Snider et al., 1992; Mu et al., 1993) . It remains unclear whether NGF may also be synthesized in spinal cord at early developmental stages. Whether rate of growth of axons in other developing CNS pathways may also be regulated by growth factors is unknown, but this issue can be studied using approaches similar to the one outlined here.
A final important point with regard to NGF effects on dorsal root axons is that NGF action did not completely override normal spatial cues. Thus, NGF-stimulated axons almost invariably remained in the dorsal horn. Even when massive growth of axon bundles was stimulated, axons grew contralaterally to the dorsal horn on the opposite side of the spinal cord and never into the ventral horn. A logical interpretation of this finding is that surface molecules normally constrain the growth of DRG axons to certain regions of the spinal cord and that the actions of these molecules are not completely overridden by increasing the available supply of NGF.
Enhancement of axon growth by NGF is selective A clear-cut conclusion from the present findings is that regulatory influences of NGF on dorsal root axon growth are strikingly selective. It was readily apparent that axons stimulated by NGF were restricted to the dorsal horn, whereas axons projecting to the ventral horn did not respond. Furthermore, it was straightforward using our approach to show that growth cones of certain classes of dorsal root afferents were markedly enlarged, while those of other classes were not.
Almost certainly this striking selectivity is associated with expression of the trkA proto-oncogene by a subclass of DRG neurons. It is now clear that the trk family of receptor tyrosine kinases mediates the biological actions of neurotrophins either independently or in association with ~75 (Klein et al., 1989 (Klein et al., , 1990 Martin-Zanca et al., 1990; Cordon-Card0 et al., 1991; Lamballe et al., 1991; Soppet et al., 1991) . mRNA for trkA, the NGF high-affinity receptor, is expressed in DRGs from an early stage of development, at least by E12, and thus trkA could clearly mediate the effects observed in the experiments carried out here (Emfors et al., 1992; Schecterson and Bothwell, 1992; Mu et al., 1993) . Furthermore, trkA is expressed only in a subset of DRG neurons. Size-frequency histograms show that trkA is expressed by DRG neurons with soma areas at the smaller end of the spectrum . This latter finding is consistent with our observations that mNGF stimulates fibers that enter laterally and normally terminate in the superficial dorsal horn. We suggest that mNGF regulates rate of growth of dorsal root axons but does so only for those that express the appropriate receptor tyrosine kinase, trkA.
It is important to point out that not all previous experiments are consistent with the idea that effects of exogenous NGF on DRG neurons are selective. For example, in chick, NGF saves both "large" ventrolateral and "small" dorsomedial DRG neurons from naturally occurring cell death (Hamburger et al., 198 1) . Some experiments assessing effects of NGF on cell death after axotomy in the neonatal period have suggested that NGF saves virtually all cells that die in this setting (see Johnson et al., 1986 , for a review). Furthermore, one study showed clear-cut effects on synaptic transmission of Ia afferents in neonatal rats, and another study showed effects on muscle spindles, the peripheral receptors of Ia afferents Sekiya et al., 1986) . Finally, it has been reported that NGF is effective in preventing deleterious effects of cis platinum neuropathy, a neuropathy thought to influence primarily large, proprioceptive DRG axons (Apfel et al., 1992) .
It is interesting to consider why NGF apparently has effects on a variety of DRG cell classes in these latter experimental paradigms, and whether the results presented here are in conflict with these findings. In axotomy paradigms, it is possible that DRG neurons that do not normally express trkA may do so after axotomy, thus allowing them to respond to NGF. This issue is currently under active investigation (Tetzlaff et al., 1992) . A second issue to consider is that NGF may stimulate local production of neurotrophins within the DRG. It has recently been established that mRNAs for other neurotrophins, BDNF, and probably NT-3 are localized to DRG neurons (Emfors and Persson, 199 1; Schecterson and Bothwell, 1992) . If these DRG neurons express trkA, then administration of exogenous NGF should stimulate production of BDNF and NT-3 within the DRG. This may lead to increased survival of other DRG cell classes (although not necessarily increases in neurite outgrowth; see below). Determining whether mRNA for other neurotrophins is stimulated after NGF administration, and whether t&A and BDNF or NT-3 expression are colocalized should be straightforward and should ultimately allow resolution of these seemingly contradictory findings.
Inhibition of dorsal root axon growth by NT-3 A surprising and striking result of this study is that we were unable to generalize the effects of mNGF on dorsal root axon growth to other neurotrophins. Thus, hrBDNF had no clear-cut effects and hrNT-3 had a surprising inhibitory effect on axon growth at early developmental stages. In interpreting these findings, it is important to examine potential limitations of our experimental paradigms. One explanation for the lack of stimulation of DRG axon growth in our experiments would be lack of appropriate biological activity of the human recombinant neurotrophins. Strongly against the idea that human recombinant factors are inactive is the finding of increased DRG neuron soma areas in animals treated with hrNT-3. Size-frequency histograms of DRG neurons showed a clear-cut shift to larger soma areas in a completely different pattern than that observed after treatment with mNGF. A particularly striking finding was that after hrNT-3 treatment, we encountered DRG neurons with soma areas larger than any encountered in control populations. The finding that NT-3 preferentially influences large cells is consistent with the fact that trkC is preferentially expressed by large DRG neurons and that NT-3 supports DRG neurons in vitro that have been retrogradely labeled from muscle (HoryLee et al., 1993; Mu et al., 1993) . That NT-3 is a physiologically relevant growth factor for large proprioceptive DRG neurons has recently been proven by the finding that Ia axons projecting to the ventral horn are absent in animals where trkC has been deleted by homologous recombination (Klein et al., in press) .
There are at least two important reasons why hrNT-3 may have inhibitory actions on DRG axon outgrowth in vivo. An interesting possible explanation is related to the widespread expression of the high-affinity NT-3 receptor trkC, by supporting satellite and Schwann cells in the DRG, and by virtually all neurons and many glial cells in the spinal cord (Carroll et al., 1992; Emfors et al., 1992; Mu et al., 1993; Yan et al., 1993) . This pattern stands in contrast to the strikingly restricted expression of the high-affinity NGF receptor, trkA (Carroll et al., 1992; Emfors et al., 1992; Mu et al., 1993; Yan et al., 1993) . Many of these trkC receptors, particularly those on Schwann cells and glial cells, are isoforms that lack the tyrosine kinase domain (Klein et al., 1990; Middlemas et al., 1991; Lamballe et al., 1993; Tsoulfas et al., 1993) . Although the function subserved by these noncatalytic isoforms is unknown, it has been hypothesized that their expression by Schwann cells and glia may influence axon growth in the setting of development and regeneration (Beck et al., 1993; Frisen et al., 1993) . Whatever the function of these noncatalytic receptors, it seems plausible that widespread, high-affinity binding of NT-3 along the pathways of NT-3-responsive dorsal root axons may influence their growth and branching.
It is important to emphasize that these results do not exclude a chemotropic role for NT-3 in attracting axons to their appropriate central target fields (motor pools, dorsal column nuclei). Experiments in vitro utilizing compartmentalized cultures show that phosphorylation of trk and neurite elongation may be regulated by factors applied in the compartment containing neurites, whereas the same factors applied to the compartment containing the cell somata are ineffective (Senger and Campenot, 1993) . Indeed, motor neurons express NT-3 mRNA well prior to the arrival of Ia axons in motor pools, consistent with a role for NT-3 in attracting Ia axons to their central target fields. Furthermore, injection of NT-3 (but not BDNF) in spinal cord causes sprouting of axons of corticospinal neurons that are known to express trkC (Schnell et al., 1994) . If NT-3 indeed functions as a chemotropic factor, then systemic injections of the factor may disrupt the concentration gradients between developing white and gray matter necessary for the factor to attract growing axons. In support of this idea is a recent study where NGF was overexpressed in SCG cells in transgenic animals and branching into peripheral target fields was inhibited (Hoyle et al., 1993) .
Finally, it is important to point out that NT-3 may enhance survival and cell size, but not axon growth. It is increasingly apparent that the NGF-sympathetic ganglion cell model where NGF regulates almost all aspects of ganglion cell biology does not generalize to other neuronal types. Thus, there are numerous examples of situations where a factor regulates survival but not synthesis of transmitter enzymes (Hagg et al., 1992; Yan et al., 1993) . It is entirely possible that NT-3 does not regulate gene expression for molecules (e.g., tubulin, MAPS, or GAP43) important for growth cone or axon extension. These mediators of axon growth could be regulated by other growth factors or surface molecules in trkC-expressing neurons. Whether or not NT-3 does regulate gene expression for cytoskeletal elements should be readily testable both in vitro and in vivo.
Note added in proof It has recently been demonstrated that NT-3 does in fact regulate TLu,-tubulin and GAP-43 gene expression in injured rubrospinal neurons (W. Tetzlaff, personal communication) .
